ORION OYJ

ORNBV
Delayed Nasdaq Helsinki - 11:29 2022-12-02 am EST
51.72 EUR +0.62%

Turn to zoom
Prev.51.40000000
Open51.40000000
High51.78000000
Low50.78000000
Volume166 684
Latest news
11/10
11/04
11/04
11/04
Chart ORION OYJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance55,655,656,1
Spread/Res.-6,9%-6,9%-7,7%
Spread/Supp.8,9%23%23%
Support47,542,142,1
Financials
Sales 2022 1 260 M 1 321 M 1 321 M
Net income 2022 361 M 378 M 378 M
Net cash 2022 153 M 161 M 161 M
P/E ratio 2022 20,1x
Yield 2022 3,27%
Capitalization 7 261 M 7 621 M 7 613 M
EV / Sales 2022 5,64x
EV / Sales 2023 5,90x
Nbr of Employees 3 527
Free-Float 89,1%
Company
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (48.3%);
- patented prescription products (37.3%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases,...
Sector :
Other Pharmaceuticals
Calendar :
2023-02-09 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 51,72 €
Average target price 39,96 €
Spread / Average Target -22,7%